<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01567280</url>
  </required_header>
  <id_info>
    <org_study_id>DFIDM-1101</org_study_id>
    <nct_id>NCT01567280</nct_id>
  </id_info>
  <brief_title>International Cross-sectional and Longitudinal Assessment on Asthma Control (Liaison)</brief_title>
  <acronym>LIAISON</acronym>
  <official_title>International Cross-sectional and Longitudinal Assessment on Asthma Control (Liaison)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chiesi Farmaceutici S.p.A.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chiesi Farmaceutici S.p.A.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study design consists of a cross-sectional survey on the clinical characteristics of&#xD;
      patients with asthma and their level of asthma control and current quality of life, and on a&#xD;
      prospective evaluation of the rate of switch from the uncontrolled/poorly controlled&#xD;
      condition to the status of controlled asthma. Asthma control will be based on the Asthma&#xD;
      Control Questionnaire scoring system, that has been fully validated for use in both clinical&#xD;
      practice and clinical trials and has strong discriminative properties which means that it can&#xD;
      detect small differences between patients with different levels of asthma control and it is&#xD;
      very sensitive to within-patient change in asthma control over time.&#xD;
&#xD;
      Quality of life as a reflection of the control of the disease, will also be evaluated by&#xD;
      means of the Mini Asthma Quality of Life Questionnaire scoring system.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Asthma Control Questionnaire score</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Mini Asthma Quality of Life Questionnaire score</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">8111</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Controlled patients</arm_group_label>
    <description>Asthmatic patients with controlled asthma (according to ACQ score)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Partly controlled/Uncontrolled patients</arm_group_label>
    <description>Patients with partly controlled or uncontrolled asthma (according to ACQ score)</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Asthmatic patients (in treatment with the same antiasthmatic therapy for at least 4 weeks)&#xD;
        visiting the centre.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Inclusion criteria:&#xD;
&#xD;
               1. Written informed consent obtained.&#xD;
&#xD;
               2. Male or female adult (at least 18 years of age) patients with asthma diagnosed&#xD;
                  (according to GINA guidelines and confirmed by a chest physician) for at least 6&#xD;
                  months.&#xD;
&#xD;
               3. Patients in treatment with the same antiasthmatic drugs in the last 4 weeks&#xD;
                  before enrolment.&#xD;
&#xD;
          -  Exclusion criteria:&#xD;
&#xD;
               1. Patients enrolled in clinical trial in the previous 4 weeks or subjects already&#xD;
                  admitted in this study.&#xD;
&#xD;
               2. Patients suffering from conditions and illnesses that might interfere with the&#xD;
                  study purpose, according to the investigator's evaluation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Azienda Sanitaria Firenze Piero Palagi</name>
      <address>
        <city>Firenze</city>
        <zip>50125</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Braido F, Brusselle G, Ingrassia E, Nicolini G, Price D, Roche N, Soriano JB, Worth H; LIAISON study group. InternationaL cross-sectIonAl and longItudinal assessment on aSthma cONtrol in European adult patients--the LIAISON study protocol. BMC Pulm Med. 2013 Mar 25;13:18. doi: 10.1186/1471-2466-13-18.</citation>
    <PMID>23530817</PMID>
  </reference>
  <results_reference>
    <citation>Braido F, Brusselle G, Guastalla D, Ingrassia E, Nicolini G, Price D, Roche N, Soriano JB, Worth H; LIAISON Study Group. Determinants and impact of suboptimal asthma control in Europe: The INTERNATIONAL CROSS-SECTIONAL AND LONGITUDINAL ASSESSMENT ON ASTHMA CONTROL (LIAISON) study. Respir Res. 2016 May 14;17(1):51. doi: 10.1186/s12931-016-0374-z.</citation>
    <PMID>27179604</PMID>
  </results_reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>March 29, 2012</study_first_submitted>
  <study_first_submitted_qc>March 29, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 30, 2012</study_first_posted>
  <last_update_submitted>July 30, 2020</last_update_submitted>
  <last_update_submitted_qc>July 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

